Unihealth Hospitals (NSE:UNIHEALTH) ROE %: 16.03% (As of Mar. 2025) — 34% Below Median


NSE:UNIHEALTH Unihealth Hospitals Ltd NSE:UNIHEALTH
46 GF Score
Price ₹709.95
! 7 Warning Signs
View Full Analysis

What is Unihealth Hospitals ROE %?

Unihealth Hospitals NSE:UNIHEALTH -0.91% 46 ROE % is 16.03% as of Mar. 2025, which is 34% below its 10-year median of 24.11. GuruFocus rates NSE:UNIHEALTH with a GF Score™ of 46/100. The stock has 7 warning signs investors should review. Among 624 Healthcare Providers & Services companies, Unihealth Hospitals ranks better than 77.24% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Unihealth Hospitals's annualized net income for the quarter that ended in Mar. 2025 was ₹151.4 Mil. Unihealth Hospitals's average Total Stockholders Equity over the quarter that ended in Mar. 2025 was ₹944.7 Mil. Therefore, Unihealth Hospitals's annualized ROE % for the quarter that ended in Mar. 2025 was 16.03%.

The historical rank and industry rank for Unihealth Hospitals's ROE % or its related term are showing as below:

NSE:UNIHEALTH' s ROE % Range Over the Past 10 Years
Min: -14.89   Med: 24.11   Max: 61.14
Current: 16.03

During the past 6 years, Unihealth Hospitals's highest ROE % was 61.14%. The lowest was -14.89%. And the median was 24.11%.

NSE:UNIHEALTH's ROE % is ranked better than
77.24% of 624 companies
in the Healthcare Providers & Services industry
Industry Median: 5.85 vs NSE:UNIHEALTH: 16.03

Unihealth Hospitals  (NSE:UNIHEALTH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2025 )
=Net Income/Total Stockholders Equity
=151.398/944.733
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(151.398 / 555.884)*(555.884 / 1211.49)*(1211.49 / 944.733)
=Net Margin %*Asset Turnover*Equity Multiplier
=27.24 %*0.4588*1.2824
=ROA %*Equity Multiplier
=12.5 %*1.2824
=16.03 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2025 )
=Net Income/Total Stockholders Equity
=151.398/944.733
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (151.398 / 172.83) * (172.83 / 160.167) * (160.167 / 555.884) * (555.884 / 1211.49) * (1211.49 / 944.733)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.876 * 1.0791 * 28.81 % * 0.4588 * 1.2824
=16.03 %

Note: The net income data used here is one times the annual (Mar. 2025) net income data. The Revenue data used here is one times the annual (Mar. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Unihealth Hospitals ROE % Related Terms


Unihealth Hospitals ROE % Historical Data

* Premium members only.

The historical data trend for Unihealth Hospitals's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unihealth Hospitals ROE % Chart

Unihealth Hospitals Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROE %
Get a 7-Day Free Trial 61.14 29.97 36.30 18.25 16.03

Unihealth Hospitals Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROE % Get a 7-Day Free Trial 61.14 29.97 36.30 18.25 16.03

NSE:UNIHEALTH vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Unihealth Hospitals's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unihealth Hospitals ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Unihealth Hospitals's ROE % distribution charts can be found below:

* The bar in red indicates where Unihealth Hospitals's ROE % falls into.


NSE:UNIHEALTH
46GF Score
Unihealth Hospitals Ltd NSE:UNIHEALTH
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unihealth Hospitals ROE % Calculation

Unihealth Hospitals's annualized ROE % for the fiscal year that ended in Mar. 2025 is calculated as

ROE %=Net Income (A: Mar. 2025 )/( (Total Stockholders Equity (A: Mar. 2024 )+Total Stockholders Equity (A: Mar. 2025 ))/ count )
=151.398/( (854.494+1034.972)/ 2 )
=151.398/944.733
=16.03 %

Unihealth Hospitals's annualized ROE % for the quarter that ended in Mar. 2025 is calculated as

ROE %=Net Income (Q: Mar. 2025 )/( (Total Stockholders Equity (Q: Mar. 2024 )+Total Stockholders Equity (Q: Mar. 2025 ))/ count )
=151.398/( (854.494+1034.972)/ 2 )
=151.398/944.733
=16.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Mar. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 16.03% mean?
Unihealth Hospitals (NSE:UNIHEALTH) has a ROE % of 16.03% as of Mar. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Unihealth Hospitals and its competitors. This is 34% below median its historical median of 24.11. According to the industry distribution chart, Unihealth Hospitals ranks #142 out of 624 companies in the Healthcare Providers & Services industry, placing it in the top 22.8%.
Is Unihealth Hospitals' ROE % too high?
Unihealth Hospitals' current ROE % of 16.03% is 34% below median its 10-year median of 24.11. The Healthcare Providers & Services industry median ROE % is 5.85. Unihealth Hospitals' value of 16.03% is 174% above this industry median. Based on the distribution chart, Unihealth Hospitals ranks #142 out of 624 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Unihealth Hospitals has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Unihealth Hospitals' ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Unihealth Hospitals ranks #142 out of 624 companies for ROE %. This places Unihealth Hospitals in the top 23% of its industry — outperforming the majority of peers. The industry median ROE % is 5.85. Unihealth Hospitals' value of 16.03% is 174% above this benchmark. While the company's 10-year median is 24.11 vs. the industry median of 5.85, Unihealth Hospitals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.85, based on 624 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unihealth Hospitals's current ROE % of 16.03% is 174% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Unihealth Hospitals and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unihealth Hospitals's current ROE % is 16.03%, which is 34% below median its own 10-year median of 24.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unihealth Hospitals stock overvalued right now?
Unihealth Hospitals (NSE:UNIHEALTH) has a current ROE % of 16.03%. The current ROE % is 16.03%, which is 34% below median its 10-year median of 24.11 and 174% above the Healthcare Providers & Services industry median of 5.85. Unihealth Hospitals' overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Unihealth Hospitals (NSE:UNIHEALTH), the current ROE % is 16.03% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Unihealth Hospitals Business Description

Address 156 Tardeo Road, H-13 and H-14, Everest Building, Tardeo, Mumbai, MH, IND, 400034
Unihealth Hospitals Ltd is a healthcare service provider based out of India and has an operational presence in multiple countries across the African continent. The company is predominantly engaged in the business of medical tour operators, health consultancy services, and also trades in medical equipment. The company has only one reportable Business Segment, which is Healthcare Services and Trading in its related products. Geographically, the company derives revenue from India, Uganda, Tanzania, Nigeria, the UAE, and Mauritius.
46GF Score

Get the complete analysis for NSE:UNIHEALTH

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹709.95
Price